Mon, January 22, 2024
Fri, January 19, 2024
Thu, January 18, 2024
Wed, January 17, 2024
Tue, January 16, 2024
Mon, January 15, 2024
Fri, January 12, 2024

Matthew Sykes Upgraded (TWST) to Strong Buy and Increased Target to $45 on, Jan 17th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-45-on-jan-17th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Sykes of Goldman Sachs, Upgraded "Twist Bioscience Corporation" (TWST) to Strong Buy and Increased Target from $25 to $45 on, Jan 17th, 2024.

Matthew has made no other calls on TWST in the last 4 months.



There is 1 other peer that has a rating on TWST. Out of the 1 peers that are also analyzing TWST, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Gaurav Goparaju of "Berenberg" Initiated at Strong Buy and Held Target at $27 on, Wednesday, September 27th, 2023

Publication Contributing Sources